Form 8-K - Current report:
SEC Accession No. 0001144204-18-041056
Filing Date
2018-07-31
Accepted
2018-07-31 15:01:30
Documents
2
Period of Report
2018-07-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv499798_8k.htm 8-K 17824
2 EXHIBIT 10.1 tv499798_ex10-1.htm EX-10.1 5753
  Complete submission text file 0001144204-18-041056.txt   24711
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 18980830
SIC: 2836 Biological Products, (No Diagnostic Substances)